Homeopathic teething tablets, gels harmful for kids: US FDA

Image
Press Trust of India Washington
Last Updated : Oct 01 2016 | 3:22 PM IST
Homeopathic teething tablets and gels may pose a risk to infants and children, the US Food and Drug Administration (FDA) has warned, recommending consumers to stop using the products and dispose off any in their possession.
Homeopathic teething tablets and gels are sold in retail stores and online in the US.
Consumers should seek medical care immediately if their child experiences seizures, difficulty breathing, lethargy, excessive sleepiness, muscle weakness, skin flushing, constipation, difficulty urinating or agitation after using homeopathic teething tablets or gels.
"Teething can be managed without prescription or over-the-counter remedies," said Janet Woodcock, director of the FDA's Centre for Drug Evaluation and Research.
"We recommend parents and caregivers not give homeopathic teething tablets and gels to children and seek advice from their health care professional for safe alternatives," said Woodcock.
The FDA is analysing adverse events reported to the agency regarding homeopathic teething tablets and gels, including seizures in infants and children who were given these products, since a 2010 safety alert about homeopathic teething tablets.
The agency is currently investigating this issue, including testing product samples.
Homeopathic teething tablets and gels have not been evaluated or approved by the FDA for safety or efficacy.
The agency is also not aware of any proven health benefit of the products, which are labelled to relieve teething symptoms in children.
The FDA encourages health care professionals and consumers to report adverse events or quality problems experienced with the use of homeopathic teething tablets or gels.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Oct 01 2016 | 3:22 PM IST

Next Story